HIGHLIGHTS
- who: Ibrahim Mansour Nasr from the of Medicine, Zagazig, Zagazeg have published the Article: 18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer, in the Journal: (JOURNAL)
- what: Except for prescriptions containing metformin, which should be discontinued 48 h before the study, oral diabetic medications were used as recommended. The authors assessed 18F-FDG PET/CT for the evaluation of CRC therapy.
- future: This study did not include patients who did PET/CT in the first day post treatment so to confirm its value in the prediction of success of ablation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.